Ixazomib (MLN-2238)

Produktübersicht

• Artikelname: Ixazomib (MLN-2238)
• Artikelnummer: UBP-F1111
• Hersteller Artikelnummer: F1111
• Alternativnummer: UBP-F1111-25
• Hersteller: UBPBio, LLC
• Kategorie: Sonstiges

Produktbeschreibung

Ixazomib (MLN2238) (commercial name: Ninlaro) is the first and only FDA-approved oral proteasome inhibitor for the treatment of multiple myeloma. It reversibly inhibits the chymotrypsin-like activity of proteasomes with IC50 of 3.4 nM in cell-free assay

Produkteigenschaften

• Molekulargewicht: 361.03 g/mol
• NCBI: 1072833
• Puffer: Powder, no buffer
• Quelle: chemical synthesis